Artesunate inhibits intestinal tumorigenesis through Inhibiting Wnt signalling. - GreenMedInfo Summary
Artesunate Inhibits Intestinal Tumorigenesis through Inhibiting Wnt Signaling.
Carcinogenesis. 2020 Jul 25. Epub 2020 Jul 25. PMID: 32710739
Artesunate (ART) is a clinically approved antimalarial drug and was revealed as a candidate of colorectal cancer chemopreventive agents in our drug screening system. Here, we aimed to understand the suppressive effects of ART on intestinal tumorigenesis. In vitro, ART reduced T-cell factor/lymphoid enhancer factor (TCF/LEF) promoter transcriptional activity. In vivo, ART inhibited intestinal polyp development. We found that ART reduces TCF1/TCF7 nuclear translocation by binding the Ras-related nuclear protein (RAN), suggesting that ART inhibits TCF/LEF transcriptional factor nuclear translocation by binding to RAN, thereby inhibiting Wnt signaling. Our results provide a novel mechanism through which artesunate inhibits intestinal tumorigenesis.